Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
ITJTY Stock Summary
Top 10 Correlated ETFs
ITJTY
In the News
Intesa books 66 mln euros impairment on Intrum venture
Intesa Sanpaolo has booked an impairment on its joint venture with Sweden's Intrum , Europe's biggest debt collector, in a move that highlights the challenges facing the bad loan recovery industry.
Intrum to sell large chunk of investment portfolio to Cerberus for $785 mln
Intrum said on Monday it would sell a large portion of its investment portfolio to affiliates of Cerberus Capital Management for 8.2 billion Swedish crowns ($785.41 million).
Why Intrum AB Has A Great Long-Term Upside
In this environment, we want to be looking at credit and finance companies that come to be beneficiaries of the current rate increase trend. One of my favorite companies for this is actually Intrum AB - a company you may not even have heard of.
Fear of inflation starting to kick in among European consumers, says Intrum report
Anders Engdahl, president & CEO of Intrum, speaks to CNBC on the key findings from the company's Annual European Consumer Payment report including increasing fears on the impact of inflation.
ITJTY Financial details
ITJTY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 121.96 | 136.22 | 147.23 | 161.53 | 164.92 | |
Net income per share | -2.17 | 15.18 | 25.88 | -36.3 | -1.55 | |
Operating cash flow per share | 48.77 | 70.34 | 83.11 | 53.93 | 25.64 | |
Free cash flow per share | 43.44 | 64.92 | 80.35 | 50.93 | 25.64 | |
Cash per share | 12.26 | 19.68 | 36.19 | 26.34 | 31.27 | |
Book value per share | 167.96 | 154.28 | 179.58 | 153.68 | 138.99 | |
Tangible book value per share | -117.09 | -124.96 | -108.61 | -148 | -179.63 | |
Share holders equity per share | 167.96 | 154.28 | 179.58 | 153.68 | 138.99 | |
Interest debt per share | 406.11 | 416.48 | 458.76 | 495.9 | 532.62 | |
Market cap | 35.64B | 27.3B | 28.58B | 15.26B | 7.89B | |
Enterprise value | 85.37B | 74.83B | 77.43B | 69.06B | 65.24B | |
P/E ratio | -125.06 | 14.51 | 9.14 | -3.48 | -42.19 | |
Price to sales ratio | 2.23 | 1.62 | 1.61 | 0.78 | 0.4 | |
POCF ratio | 5.58 | 3.13 | 2.85 | 2.34 | 2.55 | |
PFCF ratio | 6.26 | 3.39 | 2.94 | 2.48 | 2.55 | |
P/B Ratio | 1.62 | 1.43 | 1.32 | 0.82 | 0.47 | |
PTB ratio | 1.62 | 1.43 | 1.32 | 0.82 | 0.47 | |
EV to sales | 5.34 | 4.43 | 4.35 | 3.54 | 3.28 | |
Enterprise value over EBITDA | 13.97 | 12.08 | 9.77 | 49.97 | 11.2 | |
EV to operating cash flow | 13.36 | 8.59 | 7.71 | 10.61 | 21.11 | |
EV to free cash flow | 15 | 9.3 | 7.98 | 11.24 | 21.11 | |
Earnings yield | -0.01 | 0.07 | 0.11 | -0.29 | -0.02 | |
Free cash flow yield | 0.16 | 0.29 | 0.34 | 0.4 | 0.39 | |
Debt to equity | 2.34 | 2.59 | 2.46 | 3.09 | 3.62 | |
Debt to assets | 0.6 | 0.61 | 0.6 | 0.65 | 0.67 | |
Net debt to EBITDA | 8.14 | 7.67 | 6.16 | 38.93 | 9.84 | |
Current ratio | 0.8 | 0.69 | 0.74 | 0.69 | 0 | |
Interest coverage | 1.22 | 2.31 | 3.05 | -0.25 | 1.22 | |
Income quality | 3.1 | 1.86 | 1.55 | 42.25 | 77.25 | |
Dividend Yield | 0.03 | 0.05 | 0.05 | 0.12 | 0 | |
Payout ratio | -4.38 | 0.71 | 0.46 | -0.4 | 0 | |
Sales general and administrative to revenue | 0 | 0.1 | 0.1 | 0.12 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.47 | 0.46 | 0.43 | 0.44 | 0.44 | |
Capex to operating cash flow | -0.11 | -0.08 | -0.03 | -0.06 | 0 | |
Capex to revenue | -0.04 | -0.04 | -0.02 | -0.02 | 0 | |
Capex to depreciation | -0.16 | -0.44 | -0.22 | -0.18 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 90.65 | 229.56 | 323.37 | 354.29 | 69.65 | |
ROIC | -0.06 | 0.05 | 0.07 | -0.01 | 0.02 | |
Return on tangible assets | -0.01 | 0.04 | 0.06 | -0.09 | 0 | |
Graham Net | -424.85 | -437.65 | -465.9 | -500.14 | -547.52 | |
Working capital | -2.02B | -3.51B | -3.56B | -4.47B | -8.15B | |
Tangible asset value | -15.35B | -15.48B | -13.12B | -17.85B | -21.65B | |
Net current asset value | -52.97B | -51.01B | -53.85B | -57.52B | -72.03B | |
Invested capital | 2.34 | 2.59 | 2.46 | 3.09 | 3.62 | |
Average receivables | 4.24B | 3.81B | 3.56B | 4.83B | 3.97B | |
Average payables | 500M | 502.5M | 498.5M | 472M | 220M | |
Average inventory | 1.41B | 380.5M | 347M | 308.5M | 315.5M | |
Days sales outstanding | 114.53 | 56.09 | 92.85 | 96.11 | 51.45 | |
Days payables outstanding | 19.06 | 18.94 | 19.25 | 14.05 | 0 | |
Days of inventory on hand | 14.22 | 14.56 | 12.03 | 9.64 | 12.43 | |
Receivables turnover | 3.19 | 6.51 | 3.93 | 3.8 | 7.09 | |
Payables turnover | 19.15 | 19.27 | 18.96 | 25.98 | 0 | |
Inventory turnover | 25.67 | 25.07 | 30.33 | 37.86 | 29.37 | |
ROE | -0.01 | 0.1 | 0.14 | -0.24 | -0.01 | |
Capex per share | -5.33 | -5.42 | -2.76 | -3 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 46.12 | 37.53 | 41.08 | 40.72 | 45.85 | |
Net income per share | -29.68 | 0.58 | 3.23 | -3.41 | 1.55 | |
Operating cash flow per share | 9.25 | 13.35 | 17.12 | 11.15 | 8.88 | |
Free cash flow per share | 8.16 | 12.8 | 16.61 | 10.6 | 8.88 | |
Cash per share | 26.36 | 30.8 | 18.87 | 26.02 | 31.27 | |
Book value per share | 153.81 | 154.57 | 160.83 | 152.11 | 138.99 | |
Tangible book value per share | -148.12 | -147.47 | -159.15 | -167.1 | -179.63 | |
Share holders equity per share | 153.81 | 154.57 | 160.83 | 152.11 | 138.99 | |
Interest debt per share | 482.58 | 493.82 | 519.08 | 520.29 | 510.69 | |
Market cap | 15.24B | 13.23B | 8.47B | 7.75B | 7.89B | |
Enterprise value | 69.04B | 68.26B | 67.75B | 66.01B | 65.24B | |
P/E ratio | -1.07 | 47.24 | 5.44 | -4.72 | 10.55 | |
Price to sales ratio | 2.74 | 2.92 | 1.71 | 1.58 | 1.43 | |
POCF ratio | 13.67 | 8.22 | 4.11 | 5.77 | 7.37 | |
PFCF ratio | 15.49 | 8.57 | 4.23 | 6.07 | 7.37 | |
P/B Ratio | 0.82 | 0.71 | 0.44 | 0.42 | 0.47 | |
PTB ratio | 0.82 | 0.71 | 0.44 | 0.42 | 0.47 | |
EV to sales | 12.42 | 15.09 | 13.68 | 13.45 | 11.8 | |
Enterprise value over EBITDA | -48.52 | 57.22 | 40.3 | 76.4 | 30.7 | |
EV to operating cash flow | 61.92 | 42.42 | 32.84 | 49.12 | 60.97 | |
EV to free cash flow | 70.17 | 44.24 | 33.84 | 51.65 | 60.97 | |
Earnings yield | -0.23 | 0.01 | 0.05 | -0.05 | 0.02 | |
Free cash flow yield | 0.06 | 0.12 | 0.24 | 0.16 | 0.14 | |
Debt to equity | 3.09 | 3.15 | 3.18 | 3.37 | 3.62 | |
Debt to assets | 0.65 | 0.66 | 0.66 | 0.67 | 0.67 | |
Net debt to EBITDA | -37.81 | 46.13 | 35.26 | 67.43 | 26.99 | |
Current ratio | 0.69 | 0.69 | 0.73 | 0.66 | 0 | |
Interest coverage | 1.94 | 1.18 | 1.56 | 0.5 | 1.83 | |
Income quality | -0.97 | 1.75 | 1.6 | 2.64 | 7.64 | |
Dividend Yield | 0.01 | 0 | 0.1 | 0 | 0 | |
Payout ratio | -0.04 | 0 | 2.09 | 0 | 0 | |
Sales general and administrative to revenue | 0.41 | 0.16 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.44 | 0.44 | 0.44 | 0.44 | 0.44 | |
Capex to operating cash flow | -0.12 | -0.04 | -0.03 | -0.05 | 0 | |
Capex to revenue | -0.02 | -0.01 | -0.01 | -0.01 | 0 | |
Capex to depreciation | -0.24 | -0.21 | -0.19 | -0.18 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 320.47 | 44.94 | 108.07 | 108.03 | 69.65 | |
ROIC | 0.03 | 0.01 | 0.01 | 0 | 0 | |
Return on tangible assets | -0.07 | 0 | 0.01 | -0.01 | 0 | |
Graham Net | -500.56 | -501.66 | -542.24 | -538.21 | -547.52 | |
Working capital | -4.47B | -4.21B | -3.51B | -5.41B | -8.15B | |
Tangible asset value | -17.85B | -17.78B | -19.18B | -20.14B | -21.65B | |
Net current asset value | -57.52B | -58.15B | -62.51B | -61.95B | -72.03B | |
Invested capital | 3.09 | 3.15 | 3.18 | 3.37 | 3.62 | |
Average receivables | 5.1B | 4.7B | 4.81B | 5.37B | 4.1B | |
Average payables | 422.5M | 497M | 452.5M | 3.16B | 2.99B | |
Average inventory | 299M | 321M | 354.5M | 365.5M | 345.5M | |
Days sales outstanding | 83.07 | 84.91 | 97.2 | 98.93 | 45.63 | |
Days payables outstanding | 12.99 | 17.12 | 10.39 | 215.29 | 0 | |
Days of inventory on hand | 8.91 | 10.51 | 10.92 | 13.05 | 11.04 | |
Receivables turnover | 1.08 | 1.06 | 0.93 | 0.91 | 1.97 | |
Payables turnover | 6.93 | 5.26 | 8.66 | 0.42 | 0 | |
Inventory turnover | 10.1 | 8.56 | 8.24 | 6.9 | 8.15 | |
ROE | -0.19 | 0 | 0.02 | -0.02 | 0.01 | |
Capex per share | -1.09 | -0.55 | -0.51 | -0.55 | 0 |
ITJTY Frequently Asked Questions
What is Intrum AB (publ) stock symbol ?
Intrum AB (publ) is a SE stock and trading under the symbol ITJTY
What is Intrum AB (publ) stock quote today ?
Intrum AB (publ) stock price is $2.37 today.
Is Intrum AB (publ) stock public?
Yes, Intrum AB (publ) is a publicly traded company.